Plainsboro, NJ, United States of America

Yun Wang


Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Plainsboro, NJ (US) (2021)
  • Princeton, NJ (US) (2024)

Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Inventor Yun Wang

Introduction

Yun Wang is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of therapeutic applications, particularly in the development of antibodies targeting the IL-7 receptor.

Latest Patents

Yun Wang holds 2 patents. His latest patents include antibodies against the IL-7R alpha subunit and their uses. These antibodies are designed to bind to the alpha subunit of the IL-7 receptor (IL-7Rα). The applications of these antibodies are primarily in therapeutic settings, particularly for the treatment of inflammatory diseases. Additionally, he has developed cells that produce these antibodies, along with polynucleotides encoding the heavy and/or light chain regions of the antibodies, and vectors that comprise these polynucleotides.

Career Highlights

Yun Wang is currently employed at Bristol-Myers Squibb Company, where he continues to innovate in the field of biopharmaceuticals. His work focuses on advancing therapeutic solutions that can significantly impact patient care.

Collaborations

Yun Wang collaborates with esteemed colleagues, including Aaron Paul Yamniuk and Scott Ronald Brodeur. Their combined expertise fosters a productive environment for groundbreaking research and development.

Conclusion

Yun Wang's contributions to the field of therapeutic antibodies exemplify the impact of innovative research in medicine. His work not only advances scientific knowledge but also holds promise for improving treatment options for patients with inflammatory diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…